nodes	percent_of_prediction	percent_of_DWPC	metapath
Trametinib—CYP2C8—Torasemide—hypertension	0.04	0.0812	CbGbCtD
Trametinib—CYP2C8—Candesartan—hypertension	0.0372	0.0755	CbGbCtD
Trametinib—CYP2C8—Diltiazem—hypertension	0.0282	0.0572	CbGbCtD
Trametinib—CYP3A4—Guanethidine—hypertension	0.0234	0.0475	CbGbCtD
Trametinib—CYP2C8—Irbesartan—hypertension	0.023	0.0466	CbGbCtD
Trametinib—CYP2C8—Amlodipine—hypertension	0.0225	0.0457	CbGbCtD
Trametinib—CYP2C8—Spironolactone—hypertension	0.0221	0.0449	CbGbCtD
Trametinib—CYP2C8—Felodipine—hypertension	0.0217	0.0441	CbGbCtD
Trametinib—CYP2C8—Nifedipine—hypertension	0.021	0.0427	CbGbCtD
Trametinib—CYP2C8—Nicardipine—hypertension	0.0207	0.042	CbGbCtD
Trametinib—CYP3A4—Hydralazine—hypertension	0.0177	0.036	CbGbCtD
Trametinib—CYP2C8—Atorvastatin—hypertension	0.0162	0.0329	CbGbCtD
Trametinib—CYP3A4—Guanfacine—hypertension	0.0151	0.0306	CbGbCtD
Trametinib—CYP2C8—Losartan—hypertension	0.0148	0.0301	CbGbCtD
Trametinib—CYP3A4—Isradipine—hypertension	0.0134	0.0273	CbGbCtD
Trametinib—CYP2C8—Verapamil—hypertension	0.0131	0.0265	CbGbCtD
Trametinib—CYP3A4—Nisoldipine—hypertension	0.0118	0.024	CbGbCtD
Trametinib—CYP3A4—Indapamide—hypertension	0.0118	0.024	CbGbCtD
Trametinib—CYP3A4—Diltiazem—hypertension	0.0114	0.0232	CbGbCtD
Trametinib—CYP3A4—Eplerenone—hypertension	0.0114	0.0232	CbGbCtD
Trametinib—CYP3A4—Enalapril—hypertension	0.0102	0.0207	CbGbCtD
Trametinib—CYP3A4—Irbesartan—hypertension	0.00931	0.0189	CbGbCtD
Trametinib—CYP3A4—Amlodipine—hypertension	0.00913	0.0186	CbGbCtD
Trametinib—CYP3A4—Felodipine—hypertension	0.00881	0.0179	CbGbCtD
Trametinib—CYP3A4—Nifedipine—hypertension	0.00852	0.0173	CbGbCtD
Trametinib—CYP3A4—Nicardipine—hypertension	0.00838	0.017	CbGbCtD
Trametinib—CYP3A4—Carvedilol—hypertension	0.00838	0.017	CbGbCtD
Trametinib—CYP3A4—Propranolol—hypertension	0.00772	0.0157	CbGbCtD
Trametinib—CYP3A4—Clonidine—hypertension	0.00736	0.015	CbGbCtD
Trametinib—CYP3A4—Atorvastatin—hypertension	0.00656	0.0133	CbGbCtD
Trametinib—CYP3A4—Losartan—hypertension	0.006	0.0122	CbGbCtD
Trametinib—CYP3A4—Verapamil—hypertension	0.0053	0.0108	CbGbCtD
Trametinib—MAP2K2—cardiac ventricle—hypertension	0.0028	0.0685	CbGeAlD
Trametinib—MAP2K2—myocardium—hypertension	0.00263	0.0644	CbGeAlD
Trametinib—MAP2K1—brainstem—hypertension	0.00241	0.0591	CbGeAlD
Trametinib—MAP2K1—heart—hypertension	0.00209	0.0511	CbGeAlD
Trametinib—MAP2K1—smooth muscle tissue—hypertension	0.00207	0.0507	CbGeAlD
Trametinib—MAP2K1—cardiovascular system—hypertension	0.00197	0.0482	CbGeAlD
Trametinib—MAP2K1—kidney—hypertension	0.00193	0.0472	CbGeAlD
Trametinib—MAP2K2—heart—hypertension	0.00184	0.045	CbGeAlD
Trametinib—MAP2K2—smooth muscle tissue—hypertension	0.00182	0.0446	CbGeAlD
Trametinib—MAP2K2—decidua—hypertension	0.00179	0.0437	CbGeAlD
Trametinib—MAP2K2—cardiovascular system—hypertension	0.00173	0.0424	CbGeAlD
Trametinib—MAP2K2—kidney—hypertension	0.0017	0.0415	CbGeAlD
Trametinib—CYP3A4—urine—hypertension	0.00168	0.0412	CbGeAlD
Trametinib—MAP2K2—cortex of kidney—hypertension	0.00165	0.0404	CbGeAlD
Trametinib—MAP2K2—cardiac atrium—hypertension	0.00157	0.0385	CbGeAlD
Trametinib—MAP2K1—adrenal gland—hypertension	0.00156	0.0381	CbGeAlD
Trametinib—MAP2K2—medulla oblongata—hypertension	0.00148	0.0363	CbGeAlD
Trametinib—MAP2K2—adrenal gland—hypertension	0.00137	0.0336	CbGeAlD
Trametinib—MAP2K1—endocrine gland—hypertension	0.00135	0.0331	CbGeAlD
Trametinib—MAP2K1—central nervous system—hypertension	0.00122	0.0298	CbGeAlD
Trametinib—MAP2K2—endocrine gland—hypertension	0.00119	0.0291	CbGeAlD
Trametinib—MAP2K2—central nervous system—hypertension	0.00107	0.0262	CbGeAlD
Trametinib—CYP2C8—kidney—hypertension	0.000587	0.0144	CbGeAlD
Trametinib—CYP2C8—endocrine gland—hypertension	0.000412	0.0101	CbGeAlD
Trametinib—CYP3A4—kidney—hypertension	0.000398	0.00974	CbGeAlD
Trametinib—CYP3A4—endocrine gland—hypertension	0.000279	0.00683	CbGeAlD
Trametinib—CYP3A4—central nervous system—hypertension	0.000251	0.00615	CbGeAlD
Trametinib—Constipation—Betaxolol—hypertension	4.96e-05	0.00019	CcSEcCtD
Trametinib—Headache—Diltiazem—hypertension	4.95e-05	0.00019	CcSEcCtD
Trametinib—Headache—Indapamide—hypertension	4.95e-05	0.00019	CcSEcCtD
Trametinib—Pruritus—Valsartan—hypertension	4.94e-05	0.00019	CcSEcCtD
Trametinib—Dry mouth—Ramipril—hypertension	4.94e-05	0.00019	CcSEcCtD
Trametinib—Myalgia—Timolol—hypertension	4.94e-05	0.00019	CcSEcCtD
Trametinib—Arthralgia—Timolol—hypertension	4.94e-05	0.00019	CcSEcCtD
Trametinib—Rash—Carvedilol—hypertension	4.93e-05	0.000189	CcSEcCtD
Trametinib—Gastrointestinal pain—Perindopril—hypertension	4.93e-05	0.000189	CcSEcCtD
Trametinib—Dermatitis—Carvedilol—hypertension	4.93e-05	0.000189	CcSEcCtD
Trametinib—Pruritus—Olmesartan—hypertension	4.92e-05	0.000189	CcSEcCtD
Trametinib—Vomiting—Doxazosin—hypertension	4.92e-05	0.000189	CcSEcCtD
Trametinib—Decreased appetite—Losartan—hypertension	4.91e-05	0.000188	CcSEcCtD
Trametinib—Gastrointestinal pain—Irbesartan—hypertension	4.91e-05	0.000188	CcSEcCtD
Trametinib—Unspecified disorder of skin and subcutaneous tissue—Timolol—hypertension	4.91e-05	0.000188	CcSEcCtD
Trametinib—Body temperature increased—Captopril—hypertension	4.9e-05	0.000188	CcSEcCtD
Trametinib—Abdominal pain—Captopril—hypertension	4.9e-05	0.000188	CcSEcCtD
Trametinib—Headache—Carvedilol—hypertension	4.9e-05	0.000188	CcSEcCtD
Trametinib—Rash—Doxazosin—hypertension	4.88e-05	0.000187	CcSEcCtD
Trametinib—Fatigue—Losartan—hypertension	4.87e-05	0.000187	CcSEcCtD
Trametinib—Dermatitis—Doxazosin—hypertension	4.87e-05	0.000187	CcSEcCtD
Trametinib—Gastrointestinal pain—Hydrochlorothiazide—hypertension	4.87e-05	0.000187	CcSEcCtD
Trametinib—Vomiting—Fosinopril—hypertension	4.86e-05	0.000186	CcSEcCtD
Trametinib—Nausea—Propranolol—hypertension	4.85e-05	0.000186	CcSEcCtD
Trametinib—Oedema—Ramipril—hypertension	4.84e-05	0.000186	CcSEcCtD
Trametinib—Headache—Doxazosin—hypertension	4.84e-05	0.000186	CcSEcCtD
Trametinib—Dry mouth—Timolol—hypertension	4.83e-05	0.000185	CcSEcCtD
Trametinib—Constipation—Losartan—hypertension	4.83e-05	0.000185	CcSEcCtD
Trametinib—Vomiting—Eplerenone—hypertension	4.83e-05	0.000185	CcSEcCtD
Trametinib—Leukopenia—Lisinopril—hypertension	4.82e-05	0.000185	CcSEcCtD
Trametinib—Rash—Fosinopril—hypertension	4.82e-05	0.000185	CcSEcCtD
Trametinib—Dermatitis—Fosinopril—hypertension	4.81e-05	0.000185	CcSEcCtD
Trametinib—Vomiting—Nifedipine—hypertension	4.79e-05	0.000184	CcSEcCtD
Trametinib—Gastrointestinal pain—Furosemide—hypertension	4.79e-05	0.000184	CcSEcCtD
Trametinib—Rash—Eplerenone—hypertension	4.79e-05	0.000184	CcSEcCtD
Trametinib—Headache—Fosinopril—hypertension	4.79e-05	0.000184	CcSEcCtD
Trametinib—Dermatitis—Eplerenone—hypertension	4.78e-05	0.000183	CcSEcCtD
Trametinib—Diarrhoea—Valsartan—hypertension	4.78e-05	0.000183	CcSEcCtD
Trametinib—Asthenia—Clonidine—hypertension	4.78e-05	0.000183	CcSEcCtD
Trametinib—Vomiting—Verapamil—hypertension	4.77e-05	0.000183	CcSEcCtD
Trametinib—Abdominal pain—Perindopril—hypertension	4.76e-05	0.000183	CcSEcCtD
Trametinib—Body temperature increased—Perindopril—hypertension	4.76e-05	0.000183	CcSEcCtD
Trametinib—Diarrhoea—Olmesartan—hypertension	4.76e-05	0.000182	CcSEcCtD
Trametinib—Headache—Eplerenone—hypertension	4.76e-05	0.000182	CcSEcCtD
Trametinib—Rash—Nifedipine—hypertension	4.75e-05	0.000182	CcSEcCtD
Trametinib—Nervous system disorder—Ramipril—hypertension	4.75e-05	0.000182	CcSEcCtD
Trametinib—Dermatitis—Nifedipine—hypertension	4.75e-05	0.000182	CcSEcCtD
Trametinib—Abdominal pain—Irbesartan—hypertension	4.75e-05	0.000182	CcSEcCtD
Trametinib—Body temperature increased—Irbesartan—hypertension	4.75e-05	0.000182	CcSEcCtD
Trametinib—Thrombocytopenia—Ramipril—hypertension	4.74e-05	0.000182	CcSEcCtD
Trametinib—Oedema—Timolol—hypertension	4.74e-05	0.000182	CcSEcCtD
Trametinib—Rash—Verapamil—hypertension	4.73e-05	0.000181	CcSEcCtD
Trametinib—Dermatitis—Verapamil—hypertension	4.73e-05	0.000181	CcSEcCtD
Trametinib—Headache—Nifedipine—hypertension	4.72e-05	0.000181	CcSEcCtD
Trametinib—Pruritus—Clonidine—hypertension	4.71e-05	0.000181	CcSEcCtD
Trametinib—Body temperature increased—Hydrochlorothiazide—hypertension	4.71e-05	0.000181	CcSEcCtD
Trametinib—Abdominal pain—Hydrochlorothiazide—hypertension	4.71e-05	0.000181	CcSEcCtD
Trametinib—Skin disorder—Ramipril—hypertension	4.71e-05	0.000181	CcSEcCtD
Trametinib—Infection—Timolol—hypertension	4.71e-05	0.00018	CcSEcCtD
Trametinib—Headache—Verapamil—hypertension	4.7e-05	0.00018	CcSEcCtD
Trametinib—Cough—Lisinopril—hypertension	4.7e-05	0.00018	CcSEcCtD
Trametinib—Nausea—Indapamide—hypertension	4.69e-05	0.00018	CcSEcCtD
Trametinib—Nausea—Diltiazem—hypertension	4.69e-05	0.00018	CcSEcCtD
Trametinib—Hyperhidrosis—Ramipril—hypertension	4.68e-05	0.00018	CcSEcCtD
Trametinib—Asthenia—Trandolapril—hypertension	4.66e-05	0.000179	CcSEcCtD
Trametinib—Nervous system disorder—Timolol—hypertension	4.64e-05	0.000178	CcSEcCtD
Trametinib—Nausea—Carvedilol—hypertension	4.64e-05	0.000178	CcSEcCtD
Trametinib—Asthenia—Enalapril—hypertension	4.64e-05	0.000178	CcSEcCtD
Trametinib—Abdominal pain—Furosemide—hypertension	4.63e-05	0.000178	CcSEcCtD
Trametinib—Body temperature increased—Furosemide—hypertension	4.63e-05	0.000178	CcSEcCtD
Trametinib—Gastrointestinal pain—Losartan—hypertension	4.62e-05	0.000177	CcSEcCtD
Trametinib—Dizziness—Valsartan—hypertension	4.62e-05	0.000177	CcSEcCtD
Trametinib—Skin disorder—Timolol—hypertension	4.6e-05	0.000176	CcSEcCtD
Trametinib—Dizziness—Olmesartan—hypertension	4.6e-05	0.000176	CcSEcCtD
Trametinib—Pruritus—Trandolapril—hypertension	4.6e-05	0.000176	CcSEcCtD
Trametinib—Nausea—Doxazosin—hypertension	4.59e-05	0.000176	CcSEcCtD
Trametinib—Myalgia—Lisinopril—hypertension	4.58e-05	0.000176	CcSEcCtD
Trametinib—Arthralgia—Lisinopril—hypertension	4.58e-05	0.000176	CcSEcCtD
Trametinib—Body temperature increased—Betaxolol—hypertension	4.58e-05	0.000176	CcSEcCtD
Trametinib—Hyperhidrosis—Timolol—hypertension	4.58e-05	0.000176	CcSEcCtD
Trametinib—Asthenia—Telmisartan—hypertension	4.58e-05	0.000176	CcSEcCtD
Trametinib—Pruritus—Enalapril—hypertension	4.58e-05	0.000176	CcSEcCtD
Trametinib—Diarrhoea—Clonidine—hypertension	4.56e-05	0.000175	CcSEcCtD
Trametinib—Unspecified disorder of skin and subcutaneous tissue—Lisinopril—hypertension	4.55e-05	0.000175	CcSEcCtD
Trametinib—Nausea—Fosinopril—hypertension	4.54e-05	0.000174	CcSEcCtD
Trametinib—Pruritus—Telmisartan—hypertension	4.51e-05	0.000173	CcSEcCtD
Trametinib—Nausea—Eplerenone—hypertension	4.51e-05	0.000173	CcSEcCtD
Trametinib—Dry mouth—Lisinopril—hypertension	4.48e-05	0.000172	CcSEcCtD
Trametinib—Nausea—Nifedipine—hypertension	4.48e-05	0.000172	CcSEcCtD
Trametinib—Abdominal pain—Losartan—hypertension	4.47e-05	0.000171	CcSEcCtD
Trametinib—Body temperature increased—Losartan—hypertension	4.47e-05	0.000171	CcSEcCtD
Trametinib—Nausea—Verapamil—hypertension	4.46e-05	0.000171	CcSEcCtD
Trametinib—Asthenia—Captopril—hypertension	4.45e-05	0.000171	CcSEcCtD
Trametinib—Diarrhoea—Trandolapril—hypertension	4.44e-05	0.00017	CcSEcCtD
Trametinib—Vomiting—Valsartan—hypertension	4.44e-05	0.00017	CcSEcCtD
Trametinib—Diarrhoea—Enalapril—hypertension	4.43e-05	0.00017	CcSEcCtD
Trametinib—Vomiting—Olmesartan—hypertension	4.42e-05	0.00017	CcSEcCtD
Trametinib—Musculoskeletal discomfort—Ramipril—hypertension	4.41e-05	0.000169	CcSEcCtD
Trametinib—Rash—Valsartan—hypertension	4.4e-05	0.000169	CcSEcCtD
Trametinib—Dizziness—Clonidine—hypertension	4.4e-05	0.000169	CcSEcCtD
Trametinib—Dermatitis—Valsartan—hypertension	4.4e-05	0.000169	CcSEcCtD
Trametinib—Oedema—Lisinopril—hypertension	4.39e-05	0.000169	CcSEcCtD
Trametinib—Pruritus—Captopril—hypertension	4.39e-05	0.000168	CcSEcCtD
Trametinib—Rash—Olmesartan—hypertension	4.38e-05	0.000168	CcSEcCtD
Trametinib—Insomnia—Ramipril—hypertension	4.38e-05	0.000168	CcSEcCtD
Trametinib—Dermatitis—Olmesartan—hypertension	4.38e-05	0.000168	CcSEcCtD
Trametinib—Headache—Valsartan—hypertension	4.38e-05	0.000168	CcSEcCtD
Trametinib—Diarrhoea—Telmisartan—hypertension	4.37e-05	0.000167	CcSEcCtD
Trametinib—Infection—Lisinopril—hypertension	4.37e-05	0.000167	CcSEcCtD
Trametinib—Headache—Olmesartan—hypertension	4.36e-05	0.000167	CcSEcCtD
Trametinib—Asthenia—Perindopril—hypertension	4.32e-05	0.000166	CcSEcCtD
Trametinib—Musculoskeletal discomfort—Timolol—hypertension	4.32e-05	0.000166	CcSEcCtD
Trametinib—Asthenia—Irbesartan—hypertension	4.31e-05	0.000165	CcSEcCtD
Trametinib—Thrombocytopenia—Lisinopril—hypertension	4.3e-05	0.000165	CcSEcCtD
Trametinib—Dizziness—Trandolapril—hypertension	4.29e-05	0.000165	CcSEcCtD
Trametinib—Insomnia—Timolol—hypertension	4.28e-05	0.000164	CcSEcCtD
Trametinib—Dizziness—Enalapril—hypertension	4.28e-05	0.000164	CcSEcCtD
Trametinib—Asthenia—Hydrochlorothiazide—hypertension	4.27e-05	0.000164	CcSEcCtD
Trametinib—Skin disorder—Lisinopril—hypertension	4.27e-05	0.000164	CcSEcCtD
Trametinib—Pruritus—Perindopril—hypertension	4.26e-05	0.000163	CcSEcCtD
Trametinib—Pruritus—Irbesartan—hypertension	4.25e-05	0.000163	CcSEcCtD
Trametinib—Hyperhidrosis—Lisinopril—hypertension	4.25e-05	0.000163	CcSEcCtD
Trametinib—Diarrhoea—Captopril—hypertension	4.25e-05	0.000163	CcSEcCtD
Trametinib—Vomiting—Clonidine—hypertension	4.23e-05	0.000162	CcSEcCtD
Trametinib—Dizziness—Telmisartan—hypertension	4.22e-05	0.000162	CcSEcCtD
Trametinib—Pruritus—Hydrochlorothiazide—hypertension	4.21e-05	0.000162	CcSEcCtD
Trametinib—Decreased appetite—Ramipril—hypertension	4.21e-05	0.000162	CcSEcCtD
Trametinib—Asthenia—Furosemide—hypertension	4.2e-05	0.000161	CcSEcCtD
Trametinib—Rash—Clonidine—hypertension	4.2e-05	0.000161	CcSEcCtD
Trametinib—Dermatitis—Clonidine—hypertension	4.19e-05	0.000161	CcSEcCtD
Trametinib—Gastrointestinal disorder—Ramipril—hypertension	4.18e-05	0.00016	CcSEcCtD
Trametinib—Fatigue—Ramipril—hypertension	4.18e-05	0.00016	CcSEcCtD
Trametinib—Headache—Clonidine—hypertension	4.17e-05	0.00016	CcSEcCtD
Trametinib—Asthenia—Betaxolol—hypertension	4.16e-05	0.00016	CcSEcCtD
Trametinib—Nausea—Valsartan—hypertension	4.15e-05	0.000159	CcSEcCtD
Trametinib—Pruritus—Furosemide—hypertension	4.14e-05	0.000159	CcSEcCtD
Trametinib—Constipation—Ramipril—hypertension	4.14e-05	0.000159	CcSEcCtD
Trametinib—Nausea—Olmesartan—hypertension	4.13e-05	0.000158	CcSEcCtD
Trametinib—Vomiting—Trandolapril—hypertension	4.13e-05	0.000158	CcSEcCtD
Trametinib—Diarrhoea—Perindopril—hypertension	4.12e-05	0.000158	CcSEcCtD
Trametinib—Decreased appetite—Timolol—hypertension	4.12e-05	0.000158	CcSEcCtD
Trametinib—Vomiting—Enalapril—hypertension	4.11e-05	0.000158	CcSEcCtD
Trametinib—Diarrhoea—Irbesartan—hypertension	4.11e-05	0.000158	CcSEcCtD
Trametinib—Dizziness—Captopril—hypertension	4.1e-05	0.000157	CcSEcCtD
Trametinib—Pruritus—Betaxolol—hypertension	4.1e-05	0.000157	CcSEcCtD
Trametinib—Rash—Trandolapril—hypertension	4.1e-05	0.000157	CcSEcCtD
Trametinib—Dermatitis—Trandolapril—hypertension	4.09e-05	0.000157	CcSEcCtD
Trametinib—Gastrointestinal disorder—Timolol—hypertension	4.09e-05	0.000157	CcSEcCtD
Trametinib—Fatigue—Timolol—hypertension	4.08e-05	0.000157	CcSEcCtD
Trametinib—Rash—Enalapril—hypertension	4.08e-05	0.000156	CcSEcCtD
Trametinib—Dermatitis—Enalapril—hypertension	4.07e-05	0.000156	CcSEcCtD
Trametinib—Diarrhoea—Hydrochlorothiazide—hypertension	4.07e-05	0.000156	CcSEcCtD
Trametinib—Headache—Trandolapril—hypertension	4.07e-05	0.000156	CcSEcCtD
Trametinib—Vomiting—Telmisartan—hypertension	4.06e-05	0.000156	CcSEcCtD
Trametinib—Asthenia—Losartan—hypertension	4.05e-05	0.000156	CcSEcCtD
Trametinib—Headache—Enalapril—hypertension	4.05e-05	0.000155	CcSEcCtD
Trametinib—Rash—Telmisartan—hypertension	4.02e-05	0.000154	CcSEcCtD
Trametinib—Dermatitis—Telmisartan—hypertension	4.02e-05	0.000154	CcSEcCtD
Trametinib—Diarrhoea—Furosemide—hypertension	4.01e-05	0.000154	CcSEcCtD
Trametinib—Musculoskeletal discomfort—Lisinopril—hypertension	4e-05	0.000154	CcSEcCtD
Trametinib—Pruritus—Losartan—hypertension	4e-05	0.000153	CcSEcCtD
Trametinib—Headache—Telmisartan—hypertension	4e-05	0.000153	CcSEcCtD
Trametinib—Dizziness—Perindopril—hypertension	3.98e-05	0.000153	CcSEcCtD
Trametinib—Insomnia—Lisinopril—hypertension	3.97e-05	0.000152	CcSEcCtD
Trametinib—Dizziness—Irbesartan—hypertension	3.97e-05	0.000152	CcSEcCtD
Trametinib—Diarrhoea—Betaxolol—hypertension	3.97e-05	0.000152	CcSEcCtD
Trametinib—Gastrointestinal pain—Ramipril—hypertension	3.96e-05	0.000152	CcSEcCtD
Trametinib—Nausea—Clonidine—hypertension	3.96e-05	0.000152	CcSEcCtD
Trametinib—Vomiting—Captopril—hypertension	3.94e-05	0.000151	CcSEcCtD
Trametinib—Dizziness—Hydrochlorothiazide—hypertension	3.94e-05	0.000151	CcSEcCtD
Trametinib—Rash—Captopril—hypertension	3.91e-05	0.00015	CcSEcCtD
Trametinib—Dermatitis—Captopril—hypertension	3.91e-05	0.00015	CcSEcCtD
Trametinib—Headache—Captopril—hypertension	3.89e-05	0.000149	CcSEcCtD
Trametinib—Gastrointestinal pain—Timolol—hypertension	3.87e-05	0.000149	CcSEcCtD
Trametinib—Dizziness—Furosemide—hypertension	3.87e-05	0.000149	CcSEcCtD
Trametinib—Diarrhoea—Losartan—hypertension	3.87e-05	0.000148	CcSEcCtD
Trametinib—Nausea—Trandolapril—hypertension	3.86e-05	0.000148	CcSEcCtD
Trametinib—Nausea—Enalapril—hypertension	3.84e-05	0.000147	CcSEcCtD
Trametinib—Dizziness—Betaxolol—hypertension	3.83e-05	0.000147	CcSEcCtD
Trametinib—Vomiting—Perindopril—hypertension	3.83e-05	0.000147	CcSEcCtD
Trametinib—Abdominal pain—Ramipril—hypertension	3.83e-05	0.000147	CcSEcCtD
Trametinib—Body temperature increased—Ramipril—hypertension	3.83e-05	0.000147	CcSEcCtD
Trametinib—Decreased appetite—Lisinopril—hypertension	3.82e-05	0.000147	CcSEcCtD
Trametinib—Vomiting—Irbesartan—hypertension	3.82e-05	0.000146	CcSEcCtD
Trametinib—Rash—Perindopril—hypertension	3.8e-05	0.000146	CcSEcCtD
Trametinib—Dermatitis—Perindopril—hypertension	3.79e-05	0.000146	CcSEcCtD
Trametinib—Gastrointestinal disorder—Lisinopril—hypertension	3.79e-05	0.000146	CcSEcCtD
Trametinib—Nausea—Telmisartan—hypertension	3.79e-05	0.000145	CcSEcCtD
Trametinib—Fatigue—Lisinopril—hypertension	3.79e-05	0.000145	CcSEcCtD
Trametinib—Vomiting—Hydrochlorothiazide—hypertension	3.79e-05	0.000145	CcSEcCtD
Trametinib—Rash—Irbesartan—hypertension	3.79e-05	0.000145	CcSEcCtD
Trametinib—Dermatitis—Irbesartan—hypertension	3.78e-05	0.000145	CcSEcCtD
Trametinib—Headache—Perindopril—hypertension	3.77e-05	0.000145	CcSEcCtD
Trametinib—Headache—Irbesartan—hypertension	3.76e-05	0.000144	CcSEcCtD
Trametinib—Constipation—Lisinopril—hypertension	3.76e-05	0.000144	CcSEcCtD
Trametinib—Rash—Hydrochlorothiazide—hypertension	3.75e-05	0.000144	CcSEcCtD
Trametinib—Dermatitis—Hydrochlorothiazide—hypertension	3.75e-05	0.000144	CcSEcCtD
Trametinib—Body temperature increased—Timolol—hypertension	3.74e-05	0.000144	CcSEcCtD
Trametinib—Abdominal pain—Timolol—hypertension	3.74e-05	0.000144	CcSEcCtD
Trametinib—Dizziness—Losartan—hypertension	3.74e-05	0.000143	CcSEcCtD
Trametinib—Headache—Hydrochlorothiazide—hypertension	3.73e-05	0.000143	CcSEcCtD
Trametinib—Vomiting—Furosemide—hypertension	3.72e-05	0.000143	CcSEcCtD
Trametinib—Rash—Furosemide—hypertension	3.69e-05	0.000142	CcSEcCtD
Trametinib—Dermatitis—Furosemide—hypertension	3.69e-05	0.000142	CcSEcCtD
Trametinib—Vomiting—Betaxolol—hypertension	3.69e-05	0.000141	CcSEcCtD
Trametinib—Nausea—Captopril—hypertension	3.69e-05	0.000141	CcSEcCtD
Trametinib—Headache—Furosemide—hypertension	3.67e-05	0.000141	CcSEcCtD
Trametinib—Rash—Betaxolol—hypertension	3.66e-05	0.00014	CcSEcCtD
Trametinib—Dermatitis—Betaxolol—hypertension	3.65e-05	0.00014	CcSEcCtD
Trametinib—Headache—Betaxolol—hypertension	3.63e-05	0.000139	CcSEcCtD
Trametinib—Gastrointestinal pain—Lisinopril—hypertension	3.59e-05	0.000138	CcSEcCtD
Trametinib—Vomiting—Losartan—hypertension	3.59e-05	0.000138	CcSEcCtD
Trametinib—Nausea—Perindopril—hypertension	3.58e-05	0.000137	CcSEcCtD
Trametinib—Nausea—Irbesartan—hypertension	3.57e-05	0.000137	CcSEcCtD
Trametinib—Rash—Losartan—hypertension	3.56e-05	0.000137	CcSEcCtD
Trametinib—Dermatitis—Losartan—hypertension	3.56e-05	0.000137	CcSEcCtD
Trametinib—Headache—Losartan—hypertension	3.54e-05	0.000136	CcSEcCtD
Trametinib—Nausea—Hydrochlorothiazide—hypertension	3.54e-05	0.000136	CcSEcCtD
Trametinib—Nausea—Furosemide—hypertension	3.48e-05	0.000133	CcSEcCtD
Trametinib—Asthenia—Ramipril—hypertension	3.48e-05	0.000133	CcSEcCtD
Trametinib—Abdominal pain—Lisinopril—hypertension	3.47e-05	0.000133	CcSEcCtD
Trametinib—Body temperature increased—Lisinopril—hypertension	3.47e-05	0.000133	CcSEcCtD
Trametinib—Nausea—Betaxolol—hypertension	3.44e-05	0.000132	CcSEcCtD
Trametinib—Pruritus—Ramipril—hypertension	3.43e-05	0.000131	CcSEcCtD
Trametinib—Asthenia—Timolol—hypertension	3.4e-05	0.00013	CcSEcCtD
Trametinib—Nausea—Losartan—hypertension	3.36e-05	0.000129	CcSEcCtD
Trametinib—Pruritus—Timolol—hypertension	3.35e-05	0.000129	CcSEcCtD
Trametinib—Diarrhoea—Ramipril—hypertension	3.31e-05	0.000127	CcSEcCtD
Trametinib—Diarrhoea—Timolol—hypertension	3.24e-05	0.000124	CcSEcCtD
Trametinib—Dizziness—Ramipril—hypertension	3.2e-05	0.000123	CcSEcCtD
Trametinib—Asthenia—Lisinopril—hypertension	3.15e-05	0.000121	CcSEcCtD
Trametinib—Dizziness—Timolol—hypertension	3.13e-05	0.00012	CcSEcCtD
Trametinib—Pruritus—Lisinopril—hypertension	3.11e-05	0.000119	CcSEcCtD
Trametinib—Vomiting—Ramipril—hypertension	3.08e-05	0.000118	CcSEcCtD
Trametinib—Rash—Ramipril—hypertension	3.05e-05	0.000117	CcSEcCtD
Trametinib—Dermatitis—Ramipril—hypertension	3.05e-05	0.000117	CcSEcCtD
Trametinib—Headache—Ramipril—hypertension	3.04e-05	0.000116	CcSEcCtD
Trametinib—Vomiting—Timolol—hypertension	3.01e-05	0.000116	CcSEcCtD
Trametinib—Diarrhoea—Lisinopril—hypertension	3.01e-05	0.000115	CcSEcCtD
Trametinib—Rash—Timolol—hypertension	2.99e-05	0.000115	CcSEcCtD
Trametinib—Dermatitis—Timolol—hypertension	2.98e-05	0.000114	CcSEcCtD
Trametinib—Headache—Timolol—hypertension	2.97e-05	0.000114	CcSEcCtD
Trametinib—Dizziness—Lisinopril—hypertension	2.91e-05	0.000111	CcSEcCtD
Trametinib—Nausea—Ramipril—hypertension	2.88e-05	0.00011	CcSEcCtD
Trametinib—Nausea—Timolol—hypertension	2.81e-05	0.000108	CcSEcCtD
Trametinib—Vomiting—Lisinopril—hypertension	2.79e-05	0.000107	CcSEcCtD
Trametinib—Rash—Lisinopril—hypertension	2.77e-05	0.000106	CcSEcCtD
Trametinib—Dermatitis—Lisinopril—hypertension	2.77e-05	0.000106	CcSEcCtD
Trametinib—Headache—Lisinopril—hypertension	2.75e-05	0.000106	CcSEcCtD
Trametinib—Nausea—Lisinopril—hypertension	2.61e-05	0.0001	CcSEcCtD
Trametinib—MAP2K2—Signaling Pathways—KDR—hypertension	4.64e-06	2.25e-05	CbGpPWpGaD
Trametinib—MAP2K2—Disease—PTGS2—hypertension	4.64e-06	2.25e-05	CbGpPWpGaD
Trametinib—MAP2K1—Signaling Pathways—PDGFB—hypertension	4.63e-06	2.25e-05	CbGpPWpGaD
Trametinib—MAP2K1—Signaling Pathways—FGFR1—hypertension	4.61e-06	2.24e-05	CbGpPWpGaD
Trametinib—CYP2C8—Metabolism—CTGF—hypertension	4.59e-06	2.23e-05	CbGpPWpGaD
Trametinib—MAP2K1—Developmental Biology—AKT1—hypertension	4.59e-06	2.23e-05	CbGpPWpGaD
Trametinib—CYP2C8—Metabolism—HMGCR—hypertension	4.55e-06	2.21e-05	CbGpPWpGaD
Trametinib—CYP2C8—Metabolism—GOT2—hypertension	4.55e-06	2.21e-05	CbGpPWpGaD
Trametinib—MAP2K1—Signaling Pathways—HIF1A—hypertension	4.54e-06	2.2e-05	CbGpPWpGaD
Trametinib—MAP2K1—Signaling Pathways—AGT—hypertension	4.52e-06	2.19e-05	CbGpPWpGaD
Trametinib—CYP2C8—Metabolism of lipids and lipoproteins—PIK3R1—hypertension	4.49e-06	2.18e-05	CbGpPWpGaD
Trametinib—MAP2K2—Signaling Pathways—F2—hypertension	4.47e-06	2.17e-05	CbGpPWpGaD
Trametinib—MAP2K2—Signaling Pathways—FN1—hypertension	4.47e-06	2.17e-05	CbGpPWpGaD
Trametinib—MAP2K2—Signaling Pathways—PRKCB—hypertension	4.47e-06	2.17e-05	CbGpPWpGaD
Trametinib—CYP3A4—Metabolism—CYP4A11—hypertension	4.46e-06	2.16e-05	CbGpPWpGaD
Trametinib—CYP3A4—Metabolism—CBS—hypertension	4.46e-06	2.16e-05	CbGpPWpGaD
Trametinib—CYP3A4—Metabolism—ARG2—hypertension	4.46e-06	2.16e-05	CbGpPWpGaD
Trametinib—CYP2C8—Metabolism—ADRA2A—hypertension	4.45e-06	2.16e-05	CbGpPWpGaD
Trametinib—MAP2K1—Signaling Pathways—CALM1—hypertension	4.45e-06	2.16e-05	CbGpPWpGaD
Trametinib—MAP2K1—Signaling Pathways—APOE—hypertension	4.43e-06	2.15e-05	CbGpPWpGaD
Trametinib—MAP2K1—Signaling Pathways—LEP—hypertension	4.43e-06	2.15e-05	CbGpPWpGaD
Trametinib—MAP2K1—Innate Immune System—IL6—hypertension	4.39e-06	2.13e-05	CbGpPWpGaD
Trametinib—MAP2K1—Signaling Pathways—CAV1—hypertension	4.39e-06	2.13e-05	CbGpPWpGaD
Trametinib—MAP2K2—Immune System—CDKN1A—hypertension	4.39e-06	2.13e-05	CbGpPWpGaD
Trametinib—MAP2K1—Signaling Pathways—APOA1—hypertension	4.38e-06	2.12e-05	CbGpPWpGaD
Trametinib—MAP2K2—Immune System—PTEN—hypertension	4.38e-06	2.12e-05	CbGpPWpGaD
Trametinib—MAP2K1—Disease—MTOR—hypertension	4.38e-06	2.12e-05	CbGpPWpGaD
Trametinib—MAP2K2—Signaling Pathways—NOTCH1—hypertension	4.37e-06	2.12e-05	CbGpPWpGaD
Trametinib—CYP3A4—Metabolism—XDH—hypertension	4.37e-06	2.12e-05	CbGpPWpGaD
Trametinib—MAP2K1—Immune System—IL1B—hypertension	4.37e-06	2.12e-05	CbGpPWpGaD
Trametinib—MAP2K1—Signaling Pathways—KDR—hypertension	4.34e-06	2.11e-05	CbGpPWpGaD
Trametinib—MAP2K1—Disease—PTGS2—hypertension	4.34e-06	2.1e-05	CbGpPWpGaD
Trametinib—MAP2K2—Innate Immune System—AKT1—hypertension	4.33e-06	2.1e-05	CbGpPWpGaD
Trametinib—CYP3A4—Metabolism—PTGIS—hypertension	4.29e-06	2.08e-05	CbGpPWpGaD
Trametinib—CYP3A4—Metabolism—CYP3A5—hypertension	4.29e-06	2.08e-05	CbGpPWpGaD
Trametinib—CYP3A4—Metabolism—SLC5A2—hypertension	4.29e-06	2.08e-05	CbGpPWpGaD
Trametinib—MAP2K2—Immune System—MAPK8—hypertension	4.28e-06	2.08e-05	CbGpPWpGaD
Trametinib—MAP2K1—Signaling Pathways—F2—hypertension	4.18e-06	2.03e-05	CbGpPWpGaD
Trametinib—MAP2K1—Signaling Pathways—FN1—hypertension	4.18e-06	2.03e-05	CbGpPWpGaD
Trametinib—MAP2K1—Signaling Pathways—PRKCB—hypertension	4.18e-06	2.03e-05	CbGpPWpGaD
Trametinib—MAP2K2—Immune System—EP300—hypertension	4.18e-06	2.02e-05	CbGpPWpGaD
Trametinib—CYP2C8—Metabolism—TH—hypertension	4.17e-06	2.02e-05	CbGpPWpGaD
Trametinib—CYP2C8—Metabolism—CALM2—hypertension	4.15e-06	2.01e-05	CbGpPWpGaD
Trametinib—CYP3A4—Metabolism—HSD11B1—hypertension	4.14e-06	2.01e-05	CbGpPWpGaD
Trametinib—CYP3A4—Metabolism—UCP2—hypertension	4.14e-06	2.01e-05	CbGpPWpGaD
Trametinib—CYP3A4—Metabolism—TPH1—hypertension	4.14e-06	2.01e-05	CbGpPWpGaD
Trametinib—CYP3A4—Metabolism—UCP3—hypertension	4.14e-06	2.01e-05	CbGpPWpGaD
Trametinib—CYP3A4—Metabolism—ABCC1—hypertension	4.14e-06	2.01e-05	CbGpPWpGaD
Trametinib—MAP2K1—Immune System—CDKN1A—hypertension	4.11e-06	1.99e-05	CbGpPWpGaD
Trametinib—CYP2C8—Metabolism of lipids and lipoproteins—PTGS2—hypertension	4.1e-06	1.99e-05	CbGpPWpGaD
Trametinib—MAP2K1—Immune System—PTEN—hypertension	4.1e-06	1.99e-05	CbGpPWpGaD
Trametinib—MAP2K1—Signaling Pathways—NOTCH1—hypertension	4.09e-06	1.98e-05	CbGpPWpGaD
Trametinib—MAP2K2—Signaling Pathways—POMC—hypertension	4.07e-06	1.97e-05	CbGpPWpGaD
Trametinib—MAP2K2—Immune System—SRC—hypertension	4.06e-06	1.97e-05	CbGpPWpGaD
Trametinib—CYP2C8—Metabolism—GCG—hypertension	4.06e-06	1.97e-05	CbGpPWpGaD
Trametinib—CYP2C8—Metabolism—SLC2A4—hypertension	4.06e-06	1.97e-05	CbGpPWpGaD
Trametinib—MAP2K1—Innate Immune System—AKT1—hypertension	4.05e-06	1.97e-05	CbGpPWpGaD
Trametinib—MAP2K2—Disease—CDKN1A—hypertension	4.05e-06	1.96e-05	CbGpPWpGaD
Trametinib—MAP2K2—Signaling Pathways—INS—hypertension	4.05e-06	1.96e-05	CbGpPWpGaD
Trametinib—MAP2K2—Disease—PTEN—hypertension	4.04e-06	1.96e-05	CbGpPWpGaD
Trametinib—CYP3A4—Metabolism—SLC2A3—hypertension	4.01e-06	1.95e-05	CbGpPWpGaD
Trametinib—CYP3A4—Metabolism—ALAS1—hypertension	4.01e-06	1.95e-05	CbGpPWpGaD
Trametinib—CYP3A4—Metabolism—CYP11B2—hypertension	4.01e-06	1.95e-05	CbGpPWpGaD
Trametinib—MAP2K1—Immune System—MAPK8—hypertension	4.01e-06	1.94e-05	CbGpPWpGaD
Trametinib—MAP2K2—Signaling Pathways—CCL2—hypertension	3.98e-06	1.93e-05	CbGpPWpGaD
Trametinib—CYP3A4—Metabolism—HSD3B1—hypertension	3.95e-06	1.92e-05	CbGpPWpGaD
Trametinib—CYP3A4—Metabolism—ADA—hypertension	3.95e-06	1.92e-05	CbGpPWpGaD
Trametinib—CYP2C8—Metabolism—GOT1—hypertension	3.93e-06	1.9e-05	CbGpPWpGaD
Trametinib—MAP2K2—Signaling Pathways—IGF1—hypertension	3.91e-06	1.9e-05	CbGpPWpGaD
Trametinib—MAP2K2—Signaling Pathways—AKT2—hypertension	3.91e-06	1.9e-05	CbGpPWpGaD
Trametinib—MAP2K1—Immune System—EP300—hypertension	3.91e-06	1.89e-05	CbGpPWpGaD
Trametinib—CYP3A4—Metabolism—FADS1—hypertension	3.9e-06	1.89e-05	CbGpPWpGaD
Trametinib—CYP3A4—Metabolism—AQP1—hypertension	3.9e-06	1.89e-05	CbGpPWpGaD
Trametinib—MAP2K2—Signaling by GPCR—EGFR—hypertension	3.9e-06	1.89e-05	CbGpPWpGaD
Trametinib—MAP2K2—Disease—EP300—hypertension	3.86e-06	1.87e-05	CbGpPWpGaD
Trametinib—CYP2C8—Metabolism—CYP19A1—hypertension	3.81e-06	1.85e-05	CbGpPWpGaD
Trametinib—CYP2C8—Metabolism—STK11—hypertension	3.81e-06	1.85e-05	CbGpPWpGaD
Trametinib—MAP2K1—Signaling Pathways—POMC—hypertension	3.81e-06	1.85e-05	CbGpPWpGaD
Trametinib—MAP2K1—Immune System—SRC—hypertension	3.8e-06	1.84e-05	CbGpPWpGaD
Trametinib—MAP2K1—Disease—CDKN1A—hypertension	3.79e-06	1.84e-05	CbGpPWpGaD
Trametinib—CYP3A4—Metabolism—TBXAS1—hypertension	3.79e-06	1.84e-05	CbGpPWpGaD
Trametinib—CYP3A4—Metabolism—CA9—hypertension	3.79e-06	1.84e-05	CbGpPWpGaD
Trametinib—MAP2K1—Signaling Pathways—INS—hypertension	3.79e-06	1.84e-05	CbGpPWpGaD
Trametinib—MAP2K1—Disease—PTEN—hypertension	3.78e-06	1.83e-05	CbGpPWpGaD
Trametinib—MAP2K2—Disease—SRC—hypertension	3.75e-06	1.82e-05	CbGpPWpGaD
Trametinib—MAP2K1—Signaling Pathways—CCL2—hypertension	3.73e-06	1.81e-05	CbGpPWpGaD
Trametinib—MAP2K2—Signaling Pathways—SERPINE1—hypertension	3.72e-06	1.8e-05	CbGpPWpGaD
Trametinib—CYP3A4—Metabolism—ALOX15—hypertension	3.69e-06	1.79e-05	CbGpPWpGaD
Trametinib—CYP3A4—Metabolism—ALOX5AP—hypertension	3.69e-06	1.79e-05	CbGpPWpGaD
Trametinib—MAP2K1—Signaling Pathways—IGF1—hypertension	3.66e-06	1.78e-05	CbGpPWpGaD
Trametinib—MAP2K1—Signaling Pathways—AKT2—hypertension	3.66e-06	1.77e-05	CbGpPWpGaD
Trametinib—MAP2K1—Signaling by GPCR—EGFR—hypertension	3.64e-06	1.77e-05	CbGpPWpGaD
Trametinib—MAP2K1—Disease—EP300—hypertension	3.61e-06	1.75e-05	CbGpPWpGaD
Trametinib—CYP3A4—Metabolism—HADHA—hypertension	3.61e-06	1.75e-05	CbGpPWpGaD
Trametinib—CYP3A4—Metabolism—LHB—hypertension	3.61e-06	1.75e-05	CbGpPWpGaD
Trametinib—MAP2K2—Signaling Pathways—FGF2—hypertension	3.6e-06	1.75e-05	CbGpPWpGaD
Trametinib—MAP2K2—Signaling Pathways—RHOA—hypertension	3.59e-06	1.74e-05	CbGpPWpGaD
Trametinib—CYP2C8—Metabolism of lipids and lipoproteins—PTEN—hypertension	3.58e-06	1.74e-05	CbGpPWpGaD
Trametinib—MAP2K2—Immune System—EGFR—hypertension	3.56e-06	1.73e-05	CbGpPWpGaD
Trametinib—MAP2K2—Signaling Pathways—NOS3—hypertension	3.55e-06	1.72e-05	CbGpPWpGaD
Trametinib—MAP2K2—Signaling Pathways—PIK3R1—hypertension	3.55e-06	1.72e-05	CbGpPWpGaD
Trametinib—CYP2C8—Metabolism—COMT—hypertension	3.54e-06	1.72e-05	CbGpPWpGaD
Trametinib—CYP3A4—Metabolism—LPA—hypertension	3.52e-06	1.71e-05	CbGpPWpGaD
Trametinib—CYP3A4—Metabolism—HSD3B2—hypertension	3.52e-06	1.71e-05	CbGpPWpGaD
Trametinib—CYP3A4—Metabolism—KCNJ11—hypertension	3.52e-06	1.71e-05	CbGpPWpGaD
Trametinib—MAP2K1—Disease—SRC—hypertension	3.51e-06	1.7e-05	CbGpPWpGaD
Trametinib—CYP2C8—Metabolism—PPARGC1A—hypertension	3.5e-06	1.7e-05	CbGpPWpGaD
Trametinib—CYP2C8—Metabolism—GNB3—hypertension	3.5e-06	1.7e-05	CbGpPWpGaD
Trametinib—CYP2C8—Metabolism—HMOX1—hypertension	3.48e-06	1.69e-05	CbGpPWpGaD
Trametinib—MAP2K1—Signaling Pathways—SERPINE1—hypertension	3.48e-06	1.69e-05	CbGpPWpGaD
Trametinib—CYP2C8—Metabolism—CAT—hypertension	3.43e-06	1.66e-05	CbGpPWpGaD
Trametinib—CYP2C8—Metabolism of lipids and lipoproteins—EP300—hypertension	3.41e-06	1.66e-05	CbGpPWpGaD
Trametinib—CYP2C8—Metabolism—GNAS—hypertension	3.4e-06	1.65e-05	CbGpPWpGaD
Trametinib—CYP3A4—Metabolism—LRP2—hypertension	3.38e-06	1.64e-05	CbGpPWpGaD
Trametinib—CYP3A4—Metabolism—CYP2C18—hypertension	3.38e-06	1.64e-05	CbGpPWpGaD
Trametinib—MAP2K1—Signaling Pathways—FGF2—hypertension	3.37e-06	1.63e-05	CbGpPWpGaD
Trametinib—MAP2K2—Disease—MYC—hypertension	3.36e-06	1.63e-05	CbGpPWpGaD
Trametinib—MAP2K1—Signaling Pathways—RHOA—hypertension	3.36e-06	1.63e-05	CbGpPWpGaD
Trametinib—MAP2K2—Disease—TGFB1—hypertension	3.35e-06	1.63e-05	CbGpPWpGaD
Trametinib—MAP2K2—Signaling Pathways—RELA—hypertension	3.34e-06	1.62e-05	CbGpPWpGaD
Trametinib—CYP2C8—Metabolism—APOB—hypertension	3.33e-06	1.62e-05	CbGpPWpGaD
Trametinib—MAP2K1—Immune System—EGFR—hypertension	3.33e-06	1.61e-05	CbGpPWpGaD
Trametinib—MAP2K1—Signaling Pathways—NOS3—hypertension	3.32e-06	1.61e-05	CbGpPWpGaD
Trametinib—MAP2K1—Signaling Pathways—PIK3R1—hypertension	3.32e-06	1.61e-05	CbGpPWpGaD
Trametinib—MAP2K2—Disease—EGFR—hypertension	3.29e-06	1.59e-05	CbGpPWpGaD
Trametinib—MAP2K2—Signaling Pathways—MTOR—hypertension	3.28e-06	1.59e-05	CbGpPWpGaD
Trametinib—CYP3A4—Metabolism—HSPG2—hypertension	3.25e-06	1.58e-05	CbGpPWpGaD
Trametinib—CYP2C8—Metabolism—GSTM1—hypertension	3.24e-06	1.57e-05	CbGpPWpGaD
Trametinib—CYP2C8—Metabolism—LPL—hypertension	3.18e-06	1.54e-05	CbGpPWpGaD
Trametinib—MAP2K2—Signaling Pathways—CXCL8—hypertension	3.15e-06	1.53e-05	CbGpPWpGaD
Trametinib—MAP2K1—Disease—MYC—hypertension	3.14e-06	1.52e-05	CbGpPWpGaD
Trametinib—CYP3A4—Metabolism—ALOX5—hypertension	3.14e-06	1.52e-05	CbGpPWpGaD
Trametinib—CYP3A4—Metabolism—GLP1R—hypertension	3.14e-06	1.52e-05	CbGpPWpGaD
Trametinib—MAP2K1—Disease—TGFB1—hypertension	3.14e-06	1.52e-05	CbGpPWpGaD
Trametinib—MAP2K1—Signaling Pathways—RELA—hypertension	3.13e-06	1.52e-05	CbGpPWpGaD
Trametinib—CYP2C8—Metabolism—ADCY5—hypertension	3.12e-06	1.51e-05	CbGpPWpGaD
Trametinib—CYP2C8—Metabolism—GPX1—hypertension	3.1e-06	1.51e-05	CbGpPWpGaD
Trametinib—MAP2K1—Disease—EGFR—hypertension	3.07e-06	1.49e-05	CbGpPWpGaD
Trametinib—CYP2C8—Metabolism—CYP1A1—hypertension	3.07e-06	1.49e-05	CbGpPWpGaD
Trametinib—CYP2C8—Metabolism—PRKCA—hypertension	3.07e-06	1.49e-05	CbGpPWpGaD
Trametinib—MAP2K1—Signaling Pathways—MTOR—hypertension	3.07e-06	1.49e-05	CbGpPWpGaD
Trametinib—CYP2C8—Metabolism—CD36—hypertension	3.02e-06	1.47e-05	CbGpPWpGaD
Trametinib—MAP2K2—Signaling by GPCR—IL6—hypertension	2.99e-06	1.45e-05	CbGpPWpGaD
Trametinib—MAP2K1—Signaling Pathways—CXCL8—hypertension	2.95e-06	1.43e-05	CbGpPWpGaD
Trametinib—CYP3A4—Metabolism—ALDH2—hypertension	2.87e-06	1.39e-05	CbGpPWpGaD
Trametinib—CYP2C8—Metabolism—MTHFR—hypertension	2.87e-06	1.39e-05	CbGpPWpGaD
Trametinib—MAP2K2—Signaling Pathways—MMP9—hypertension	2.85e-06	1.38e-05	CbGpPWpGaD
Trametinib—MAP2K2—Signaling Pathways—CDKN1A—hypertension	2.84e-06	1.38e-05	CbGpPWpGaD
Trametinib—MAP2K2—Signaling Pathways—PTEN—hypertension	2.83e-06	1.37e-05	CbGpPWpGaD
Trametinib—CYP2C8—Metabolism—PPARA—hypertension	2.81e-06	1.36e-05	CbGpPWpGaD
Trametinib—MAP2K1—Signaling by GPCR—IL6—hypertension	2.8e-06	1.36e-05	CbGpPWpGaD
Trametinib—CYP3A4—Metabolism—HBA1—hypertension	2.8e-06	1.36e-05	CbGpPWpGaD
Trametinib—CYP3A4—Metabolism—CYP11A1—hypertension	2.78e-06	1.35e-05	CbGpPWpGaD
Trametinib—MAP2K2—Signaling Pathways—MAPK8—hypertension	2.77e-06	1.34e-05	CbGpPWpGaD
Trametinib—MAP2K2—Signaling by GPCR—AKT1—hypertension	2.76e-06	1.34e-05	CbGpPWpGaD
Trametinib—MAP2K2—Immune System—IL6—hypertension	2.74e-06	1.33e-05	CbGpPWpGaD
Trametinib—CYP3A4—Metabolism—GSTT1—hypertension	2.73e-06	1.32e-05	CbGpPWpGaD
Trametinib—CYP3A4—Metabolism—SLC9A1—hypertension	2.73e-06	1.32e-05	CbGpPWpGaD
Trametinib—CYP2C8—Metabolism—AGT—hypertension	2.72e-06	1.32e-05	CbGpPWpGaD
Trametinib—CYP3A4—Metabolism—GCLC—hypertension	2.7e-06	1.31e-05	CbGpPWpGaD
Trametinib—CYP3A4—Metabolism—CETP—hypertension	2.7e-06	1.31e-05	CbGpPWpGaD
Trametinib—MAP2K2—Signaling Pathways—EP300—hypertension	2.7e-06	1.31e-05	CbGpPWpGaD
Trametinib—CYP2C8—Metabolism—CALM1—hypertension	2.68e-06	1.3e-05	CbGpPWpGaD
Trametinib—CYP2C8—Metabolism—APOE—hypertension	2.67e-06	1.29e-05	CbGpPWpGaD
Trametinib—MAP2K1—Signaling Pathways—MMP9—hypertension	2.66e-06	1.29e-05	CbGpPWpGaD
Trametinib—MAP2K1—Signaling Pathways—CDKN1A—hypertension	2.65e-06	1.29e-05	CbGpPWpGaD
Trametinib—MAP2K1—Signaling Pathways—PTEN—hypertension	2.65e-06	1.28e-05	CbGpPWpGaD
Trametinib—CYP2C8—Metabolism—CAV1—hypertension	2.64e-06	1.28e-05	CbGpPWpGaD
Trametinib—CYP2C8—Metabolism—APOA1—hypertension	2.64e-06	1.28e-05	CbGpPWpGaD
Trametinib—MAP2K2—Signaling Pathways—SRC—hypertension	2.63e-06	1.27e-05	CbGpPWpGaD
Trametinib—MAP2K1—Signaling Pathways—MAPK8—hypertension	2.59e-06	1.26e-05	CbGpPWpGaD
Trametinib—CYP3A4—Metabolism—CYP17A1—hypertension	2.59e-06	1.25e-05	CbGpPWpGaD
Trametinib—MAP2K1—Signaling by GPCR—AKT1—hypertension	2.58e-06	1.25e-05	CbGpPWpGaD
Trametinib—CYP3A4—Metabolism—ENO1—hypertension	2.56e-06	1.24e-05	CbGpPWpGaD
Trametinib—CYP3A4—Metabolism—PTGS1—hypertension	2.56e-06	1.24e-05	CbGpPWpGaD
Trametinib—MAP2K1—Immune System—IL6—hypertension	2.56e-06	1.24e-05	CbGpPWpGaD
Trametinib—MAP2K2—Signaling Pathways—VEGFA—hypertension	2.56e-06	1.24e-05	CbGpPWpGaD
Trametinib—MAP2K1—Signaling Pathways—EP300—hypertension	2.53e-06	1.22e-05	CbGpPWpGaD
Trametinib—MAP2K2—Disease—IL6—hypertension	2.53e-06	1.22e-05	CbGpPWpGaD
Trametinib—MAP2K2—Immune System—AKT1—hypertension	2.52e-06	1.22e-05	CbGpPWpGaD
Trametinib—CYP3A4—Metabolism—CTGF—hypertension	2.46e-06	1.2e-05	CbGpPWpGaD
Trametinib—MAP2K1—Signaling Pathways—SRC—hypertension	2.46e-06	1.19e-05	CbGpPWpGaD
Trametinib—CYP3A4—Metabolism—GOT2—hypertension	2.44e-06	1.18e-05	CbGpPWpGaD
Trametinib—CYP3A4—Metabolism—HMGCR—hypertension	2.44e-06	1.18e-05	CbGpPWpGaD
Trametinib—MAP2K1—Signaling Pathways—VEGFA—hypertension	2.39e-06	1.16e-05	CbGpPWpGaD
Trametinib—CYP3A4—Metabolism—ADRA2A—hypertension	2.39e-06	1.16e-05	CbGpPWpGaD
Trametinib—MAP2K1—Disease—IL6—hypertension	2.36e-06	1.15e-05	CbGpPWpGaD
Trametinib—MAP2K1—Immune System—AKT1—hypertension	2.36e-06	1.14e-05	CbGpPWpGaD
Trametinib—MAP2K2—Signaling Pathways—MYC—hypertension	2.35e-06	1.14e-05	CbGpPWpGaD
Trametinib—MAP2K2—Signaling Pathways—TGFB1—hypertension	2.35e-06	1.14e-05	CbGpPWpGaD
Trametinib—MAP2K2—Disease—AKT1—hypertension	2.33e-06	1.13e-05	CbGpPWpGaD
Trametinib—CYP2C8—Metabolism—PPARG—hypertension	2.32e-06	1.13e-05	CbGpPWpGaD
Trametinib—MAP2K2—Signaling Pathways—EGFR—hypertension	2.3e-06	1.12e-05	CbGpPWpGaD
Trametinib—CYP2C8—Metabolism—POMC—hypertension	2.29e-06	1.11e-05	CbGpPWpGaD
Trametinib—CYP2C8—Metabolism—INS—hypertension	2.28e-06	1.11e-05	CbGpPWpGaD
Trametinib—CYP3A4—Metabolism—TH—hypertension	2.24e-06	1.09e-05	CbGpPWpGaD
Trametinib—CYP3A4—Metabolism—CALM2—hypertension	2.23e-06	1.08e-05	CbGpPWpGaD
Trametinib—MAP2K1—Signaling Pathways—MYC—hypertension	2.2e-06	1.07e-05	CbGpPWpGaD
Trametinib—MAP2K1—Signaling Pathways—TGFB1—hypertension	2.2e-06	1.06e-05	CbGpPWpGaD
Trametinib—MAP2K1—Disease—AKT1—hypertension	2.18e-06	1.06e-05	CbGpPWpGaD
Trametinib—CYP3A4—Metabolism—SLC2A4—hypertension	2.18e-06	1.06e-05	CbGpPWpGaD
Trametinib—CYP3A4—Metabolism—GCG—hypertension	2.18e-06	1.06e-05	CbGpPWpGaD
Trametinib—MAP2K1—Signaling Pathways—EGFR—hypertension	2.15e-06	1.04e-05	CbGpPWpGaD
Trametinib—CYP3A4—Metabolism—GOT1—hypertension	2.11e-06	1.02e-05	CbGpPWpGaD
Trametinib—CYP2C8—Metabolism—ALB—hypertension	2.09e-06	1.01e-05	CbGpPWpGaD
Trametinib—CYP3A4—Metabolism—STK11—hypertension	2.05e-06	9.92e-06	CbGpPWpGaD
Trametinib—CYP3A4—Metabolism—CYP19A1—hypertension	2.05e-06	9.92e-06	CbGpPWpGaD
Trametinib—CYP2C8—Metabolism—PIK3R1—hypertension	2e-06	9.69e-06	CbGpPWpGaD
Trametinib—CYP2C8—Metabolism—NOS3—hypertension	2e-06	9.69e-06	CbGpPWpGaD
Trametinib—MAP2K2—Signaling Pathways—TP53—hypertension	1.93e-06	9.37e-06	CbGpPWpGaD
Trametinib—CYP3A4—Metabolism—COMT—hypertension	1.9e-06	9.23e-06	CbGpPWpGaD
Trametinib—CYP3A4—Metabolism—GNB3—hypertension	1.88e-06	9.1e-06	CbGpPWpGaD
Trametinib—CYP3A4—Metabolism—PPARGC1A—hypertension	1.88e-06	9.1e-06	CbGpPWpGaD
Trametinib—CYP3A4—Metabolism—HMOX1—hypertension	1.87e-06	9.06e-06	CbGpPWpGaD
Trametinib—CYP3A4—Metabolism—CAT—hypertension	1.84e-06	8.94e-06	CbGpPWpGaD
Trametinib—CYP2C8—Metabolism—PTGS2—hypertension	1.83e-06	8.86e-06	CbGpPWpGaD
Trametinib—CYP3A4—Metabolism—GNAS—hypertension	1.83e-06	8.86e-06	CbGpPWpGaD
Trametinib—MAP2K1—Signaling Pathways—TP53—hypertension	1.81e-06	8.77e-06	CbGpPWpGaD
Trametinib—CYP3A4—Metabolism—APOB—hypertension	1.79e-06	8.67e-06	CbGpPWpGaD
Trametinib—MAP2K2—Signaling Pathways—IL6—hypertension	1.77e-06	8.58e-06	CbGpPWpGaD
Trametinib—CYP3A4—Metabolism—GSTM1—hypertension	1.74e-06	8.44e-06	CbGpPWpGaD
Trametinib—CYP3A4—Metabolism—LPL—hypertension	1.71e-06	8.28e-06	CbGpPWpGaD
Trametinib—CYP3A4—Metabolism—ADCY5—hypertension	1.67e-06	8.11e-06	CbGpPWpGaD
Trametinib—CYP3A4—Metabolism—GPX1—hypertension	1.67e-06	8.08e-06	CbGpPWpGaD
Trametinib—MAP2K1—Signaling Pathways—IL6—hypertension	1.65e-06	8.02e-06	CbGpPWpGaD
Trametinib—CYP3A4—Metabolism—PRKCA—hypertension	1.65e-06	8e-06	CbGpPWpGaD
Trametinib—CYP3A4—Metabolism—CYP1A1—hypertension	1.65e-06	8e-06	CbGpPWpGaD
Trametinib—MAP2K2—Signaling Pathways—AKT1—hypertension	1.63e-06	7.91e-06	CbGpPWpGaD
Trametinib—CYP3A4—Metabolism—CD36—hypertension	1.62e-06	7.87e-06	CbGpPWpGaD
Trametinib—CYP2C8—Metabolism—PTEN—hypertension	1.59e-06	7.73e-06	CbGpPWpGaD
Trametinib—CYP3A4—Metabolism—MTHFR—hypertension	1.54e-06	7.46e-06	CbGpPWpGaD
Trametinib—MAP2K1—Signaling Pathways—AKT1—hypertension	1.53e-06	7.4e-06	CbGpPWpGaD
Trametinib—CYP2C8—Metabolism—EP300—hypertension	1.52e-06	7.37e-06	CbGpPWpGaD
Trametinib—CYP3A4—Metabolism—PPARA—hypertension	1.51e-06	7.32e-06	CbGpPWpGaD
Trametinib—CYP3A4—Metabolism—AGT—hypertension	1.46e-06	7.09e-06	CbGpPWpGaD
Trametinib—CYP3A4—Metabolism—CALM1—hypertension	1.44e-06	6.97e-06	CbGpPWpGaD
Trametinib—CYP3A4—Metabolism—APOE—hypertension	1.43e-06	6.94e-06	CbGpPWpGaD
Trametinib—CYP3A4—Metabolism—CAV1—hypertension	1.42e-06	6.88e-06	CbGpPWpGaD
Trametinib—CYP3A4—Metabolism—APOA1—hypertension	1.42e-06	6.86e-06	CbGpPWpGaD
Trametinib—CYP3A4—Metabolism—PPARG—hypertension	1.25e-06	6.05e-06	CbGpPWpGaD
Trametinib—CYP3A4—Metabolism—POMC—hypertension	1.23e-06	5.96e-06	CbGpPWpGaD
Trametinib—CYP3A4—Metabolism—INS—hypertension	1.22e-06	5.93e-06	CbGpPWpGaD
Trametinib—CYP3A4—Metabolism—ALB—hypertension	1.12e-06	5.44e-06	CbGpPWpGaD
Trametinib—CYP3A4—Metabolism—PIK3R1—hypertension	1.07e-06	5.2e-06	CbGpPWpGaD
Trametinib—CYP3A4—Metabolism—NOS3—hypertension	1.07e-06	5.2e-06	CbGpPWpGaD
Trametinib—CYP3A4—Metabolism—PTGS2—hypertension	9.81e-07	4.76e-06	CbGpPWpGaD
Trametinib—CYP2C8—Metabolism—AKT1—hypertension	9.19e-07	4.45e-06	CbGpPWpGaD
Trametinib—CYP3A4—Metabolism—PTEN—hypertension	8.56e-07	4.15e-06	CbGpPWpGaD
Trametinib—CYP3A4—Metabolism—EP300—hypertension	8.16e-07	3.96e-06	CbGpPWpGaD
Trametinib—CYP3A4—Metabolism—AKT1—hypertension	4.93e-07	2.39e-06	CbGpPWpGaD
